ArticleClinical case reports2018
Liposomal bupivacaine for the management of postsurgical donor site pain in patients with burn injuries: a case series from two institutions.
Article in Clinical case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03705637 (Evaluation of Liposomal Bipivicaine in Split Thickness Skin Graft Donor Sites in Burn Patients), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of Liposomal Bipivicaine in Split Thickness Skin Graft Donor Sites in Burn Patients
Who cites it
2 citing papers in PubMed, 8 citations in OpenAlex.
- Virtual reality distraction decreases pain during daily dressing changes following haemorrhoid surgery.The Journal of international medical research · 2019Trial
- Liposomal bupivacaine for the management of postsurgical donor site pain in patients with burn injuries: a case series from two institutions.Clinical case reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Donor site pain associated with skin graft procedures is frequently intense and difficult to treat. Liposomal bupivacaine, a prolonged-release local anesthetic indicated for single-dose administration to produce postsurgical analgesia, may be a viable option in managing donor site pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.